Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2026-03-13 @ 3:22 PM
Study NCT ID:
NCT05130866
Status:
TERMINATED
Last Update Posted:
2025-10-07
First Post:
2021-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
Sponsor:
Recursion Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-10
First Submit QC Date:
None
Study First Post Date:
2021-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-01
Last Update Post Date:
2025-10-07
Last Update Post Date Type:
ESTIMATED